Cipla manufactures an extensive and comprehensive catalog of pharmaceutical formulations spanning major therapeutic segments, including both generic and branded prescription drugs. Its core manufacturing strengths lie in producing advanced respiratory inhalers, anti-retroviral therapies for HIV and AIDS management, anti-infectives, cardiovascular drugs, central nervous system agents, diabetes treatments, and oncology medications. Additionally, the company produces a wide array of everyday over-the-counter wellness items, topical creams, pain management analgesics, and nutritional supplements distributed widely across international healthcare markets.